Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|October 20, 2009
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agentsCarlo Piccinni, Chiara Sacripanti, Elisabetta Poluzzi, et al.
Frontiers in Pharmacology|February 4, 2021
Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting DatabaseLara Magro, Elena Arzenton, Roberto Leone, et al.
European Journal of Clinical Pharmacology|June 4, 2014
α1-Adrenergic receptor antagonists and gynecomastia. A case series from the Italian spontaneous reporting system and VigiBase(™)Ermelinda Viola, Sibilla Opri, Ugo Moretti, et al.
Drug Safety|July 19, 2008
Drug-related deaths: an analysis of the Italian spontaneous reporting databaseRoberto Leone, Laura Sottosanti, Maria Luisa Iorio, et al.
Drug Safety|April 5, 2013
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System databaseElisabetta Poluzzi, Emanuel Raschi, Ariola Koci, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2007
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in ItalyFrancesco Salvo, Giovanni Polimeni, Ugo Moretti, et al.
Plos One|March 19, 2015
Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across EuropeElisabetta Poluzzi, Emanuel Raschi, Brian Godman, et al.
British Journal of Clinical Pharmacology|February 18, 2015
Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting systemEmanuel Raschi, Elisabetta Poluzzi, Ariola Koci, et al.
Pharmacological Research|August 12, 2008
Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF)Francesco Salvo, Giovanni Polimeni, Paola Maria Cutroneo, et al.
Expert Opinion on Drug Safety|September 15, 2019
Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®Carla Carnovale, Faizan Mazhar, Elena Arzenton, et al.
Pageof 8